Serum IL-10 and Oncostatin M as Exploratory Biomarkers Potentially Linked to Macrophage Polarization in Acute Myeloid Leukemia: Treatment-Associated Dynamics and Clinical Correlates
Background/Objectives: Acute myeloid leukemia (AML) is associated with the remodeling of the bone marrow microenvironment, including reported M2-like macrophage polarization and STAT3-associated signaling. Interleukin-10 (IL-10) and oncostatin M (OSM) are candidate circulating correlates of this state, but their combined diagnostic, induction-associated, and clinical relationships in AML are poorly characterized. This exploratory study evaluated serum IL-10 and OSM as circulating biomarkers potentially linked to the AML-associated immunoregulatory microenvironment. Methods: Forty-two newly diagnosed AML patients (nine aged <18 years) were prospectively enrolled at a single center. Serum was collected at diagnosis (pre-induction; n = 32), 28 days after the start of induction (post-induction; n = 20, all matched), and from 21 healthy volunteers. Serum IL-10 and OSM were quantified by sandwich ELISA (detection ranges 1.56–100 and 15.63–1000 pg/mL, respectively) and evaluated in relation to hematological, biochemical, and clinical parameters (correlations, n = 31), remission, and overall survival (n = 34; cytokine models n = 25). Results: Both cytokines completely separated AML patients from healthy volunteers within this study cohort (AUC = 1.000 for each) and declined after induction while remaining above control levels; although, this finding requires external validation. Pre-induction OSM correlated inversely with lymphocyte percentage (ρ = −0.60, p < 0.001), and positively with granulocyte percentage (ρ = +0.65, p < 0.001), reciprocal components of one three-part differential; both remained significant after Bonferroni correction and persisted in adults only. The lymphocyte association was attenuated after adjustment for blast percentage, whereas the granulocyte association was not; absolute lymphocyte count was not reduced. Neither cytokine correlated significantly with blast burden, remission status or survival status, and no association with survival was detected. A combined IL-10 + OSM panel showed no cross-validated advantage over IL-10. Conclusions: IL-10 and OSM were markedly elevated at diagnosis, declined after induction, and differed in their associations, with OSM tracking a myeloid-skewed differential whereas IL-10 showed only nominal associations, supporting them as biologically distinct circulating correlates of an AML-associated immunoregulatory microenvironment. These findings are compatible with, but do not demonstrate, a convergent macrophage/stromal–STAT3 framework. Because macrophage phenotype, OSMR expression and pSTAT3 were not measured, this framework requires direct cellular validation, together with disease controls and independent cohorts.
Authors
- Goran Qader Othman (ORCID: https://orcid.org/0000-0002-0880-042X)
- Shukur Wasman Smail (ORCID: https://orcid.org/0000-0001-8188-2540)
- Measer Abdullah Ahmed (ORCID: https://orcid.org/0000-0002-0157-6138)
- Kvan Omar Ahmed (ORCID: https://orcid.org/0000-0003-0223-812X)
Institutions
- University of Kirkuk (IQ)
- Uppsala University (SE)
- Cihan University-Erbil (IQ)
- Uppsala University Hospital (SE)
- Erbil Polytechnic University (IQ)
- Salahaddin University-Erbil (IQ)
- University of Tikrit (IQ)
Publication Details
- Journal
- Current Issues in Molecular Biology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3390/cimb48111229
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00